GEN

Genesis Healthcare, Inc.

GEN

Delisted

GEN was delisted on the 25th of March, 2021.

Back to rankings

Financial journalist opinion

Zacks Investment Research

Why Gen Digital (GEN) International Revenue Trends Deserve Your Attention

Examine Gen Digital's (GEN) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

Why Gen Digital (GEN) International Revenue Trends Deserve Your Attention

Zacks Investment Research

Why Gen Digital (GEN) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Why Gen Digital (GEN) is a Top Value Stock for the Long-Term

GOBankingRates Taps America's Top 100 Money Experts To Answer 2025's Most Critical Money Questions

GOBankingRates researched the top personal finance questions Americans are actively searching for online and gathered insights from the biggest names in the industry. TEMPE, Ariz.

GOBankingRates Taps America's Top 100 Money Experts To Answer 2025's Most Critical Money Questions

Zacks Investment Research

Gen Digital Q1 Earnings Surpass Expectations, Revenues Rise Y/Y

GEN posts strong Q1 earnings and revenue growth as AI-driven cyber threats boost demand for its safety solutions.

Gen Digital Q1 Earnings Surpass Expectations, Revenues Rise Y/Y

Gen Digital Inc. (GEN) Q1 2026 Earnings Call Transcript

Gen Digital Inc. (NASDAQ:GEN ) Q1 2026 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Jason Starr - Head of Investor Relation Natalie Marie Derse - Chief Financial Officer Vincent Pilette - Chairman & CEO Conference Call Participants Andrew James Nowinski - Wells Fargo Securities, LLC, Research Division Daniel Robert Bergstrom - RBC Capital Markets, Research Division Robert James Coolbrith - Evercore ISI Institutional Equities, Research Division Roger Foley Boyd - UBS Investment Bank, Research Division Saket Kalia - Barclays Bank PLC, Research Division Operator Good afternoon, everyone, and thank you for standing by. My name is Jayla, and I will be your conference operator today.

Gen Digital Inc. (GEN) Q1 2026 Earnings Call Transcript

Zacks Investment Research

Gen Digital (GEN) Beats Q1 Earnings and Revenue Estimates

Gen Digital (GEN) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.6 per share. This compares to earnings of $0.53 per share a year ago.

Gen Digital (GEN) Beats Q1 Earnings and Revenue Estimates

Gen Digital raises annual revenue and profit outlook on cybersecurity demand

Antivirus software provider Gen Digital raised its annual revenue and profit targets on Thursday, benefiting from strong demand for its cybersecurity tools.

Gen Digital raises annual revenue and profit outlook on cybersecurity demand

Gen Delivers Double-Digit Growth in Q1 FY26

Gen Raises its Annual Guidance on Better-Than-Expected Results TEMPE, Ariz. and PRAGUE , Aug. 7, 2025 /PRNewswire/ -- Gen Digital Inc. (NASDAQ: GEN), a global leader dedicated to powering Digital Freedom, released its results for its first quarter fiscal year 2026, which ended July 4, 2025.

Gen Delivers Double-Digit Growth in Q1 FY26

Zacks Investment Research

Stay Ahead of the Game With Gen Digital (GEN) Q1 Earnings: Wall Street's Insights on Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Gen Digital (GEN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.

Stay Ahead of the Game With Gen Digital (GEN) Q1 Earnings: Wall Street's Insights on Key Metrics

Zacks Investment Research

Gen Digital to Report Q1 Earnings: What's in Store for the Stock?

GEN's Q1 results are expected to show strong growth in cybersecurity and identity protection revenues, driven by new AI features and client gains.

Gen Digital to Report Q1 Earnings: What's in Store for the Stock?

See News Rankings

Charts implemented using Lightweight Charts™